These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4290035)

  • 21. Characterization of serological responses to pertussis.
    Watanabe M; Connelly B; Weiss AA
    Clin Vaccine Immunol; 2006 Mar; 13(3):341-8. PubMed ID: 16522775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between mouse intracerebral potency & 50 per cent histamine sensitizing dose of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Indian J Med Res; 1989 May; 89():144-9. PubMed ID: 2476391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test.
    Hoonakker ME; Verhagen LM; van der Maas L; Sloots A; Hendriksen CFM
    Vaccine; 2017 Feb; 35(8):1152-1160. PubMed ID: 28129894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.
    Lima FA; Miyaji EN; Quintilio W; Raw I; Ho PL; Oliveira ML
    Vaccine; 2013 May; 31(20):2465-70. PubMed ID: 23541622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
    Sato Y; Sato H
    Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative investigations into the mouse-protective potency, histamine-sensitizing activity and agglutinin-producing ability of pertussis vaccines.
    JOO I; PUSZTAI Z; JUHASZ VP
    Z Immun exp ther; 1961 May; 121():250-66. PubMed ID: 13790655
    [No Abstract]   [Full Text] [Related]  

  • 27. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines.
    Jensen SE; Illigen KE; Badsberg JH; Hasløv KR
    Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SENSITIZING PROPERTIES OF B. PERTUSSIS IN THE MOUSE AND RAT.
    GOEZSY B; KATO L
    Rev Can Biol; 1964 Sep; 23():427-37. PubMed ID: 14237174
    [No Abstract]   [Full Text] [Related]  

  • 29. The sensitizing action of Bordetella pertussis vaccine.
    Arora S; Sanyal RK; West GB
    Int Arch Allergy Appl Immunol; 1970; 37(4):357-65. PubMed ID: 4391480
    [No Abstract]   [Full Text] [Related]  

  • 30. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Wagner LD; Corvette LJ; Ngundi MM; Burns DL
    Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the structure of O-specific lipopolysaccharide (O-antigen) in Escherichia coli 020:K61:H-. I. The oxidation of O-specific lipopolysaccharide by sodium periodate and its reduction by sodium borohydride].
    Kovalenko EA; Vasil'ev VN; Zakharova IIa
    Mikrobiol Zh; 1976; 38(3):317-9. PubMed ID: 59897
    [No Abstract]   [Full Text] [Related]  

  • 32. Independent segregation of the H-2 locus and the locus for responsiveness to histamine-sensitizing factor.
    Ovary Z; Vris TW; de Szalay C; Vaz NM; Iritani CA
    Proc Natl Acad Sci U S A; 1973 Sep; 70(9):2500-1. PubMed ID: 4354853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the histamine sensitizing effect of various types of pertussis vaccine].
    Panysheva AM; Chesnokova MP
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):135-6. PubMed ID: 6004728
    [No Abstract]   [Full Text] [Related]  

  • 34. Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin.
    Rappuoli R; Pizza M; De Magistris MT; Podda A; Bugnoli M; Manetti R; Nencioni L
    Immunobiology; 1992 Feb; 184(2-3):230-9. PubMed ID: 1587545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines.
    Jensen SE; Engelhart Illigen KE; Hasløv KR
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis toxin pretreatment reveals differential effects of adenosine analogs on IgE-dependent histamine and peptidoleukotriene release from RBL-2H3 cells.
    Gilfillan AM; Wiggan GA; Welton AF
    Biochim Biophys Acta; 1990 May; 1052(3):467-74. PubMed ID: 2162218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Bordetella pertussis vaccine on the histamine metabolism of rat tissues.
    Csaba B; Muszbek L; Kassay L
    Acta Microbiol Acad Sci Hung; 1969; 16(3):211-8. PubMed ID: 4191126
    [No Abstract]   [Full Text] [Related]  

  • 38. Construction and characterization of genetically inactivated pertussis toxin.
    Brown DR; Keith JM; Sato H; Sato Y
    Dev Biol Stand; 1991; 73():63-73. PubMed ID: 1778335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of macrophage response to brain injury. A new effect of pertussis vaccine possibly related to histamine-sensitizing factor.
    Levine S; Sowinski R
    Am J Pathol; 1972 May; 67(2):349-60. PubMed ID: 4553663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A new process of inactivation for preparation of vaccines].
    Relyveld EH; Girard O; Cheyroux M; Asso J; de Rudder J
    Dev Biol Stand; 1974; 27():236-48. PubMed ID: 4218994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.